Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crestor, Rosuvastatin”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00653445
What this trial is testing

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg

Who this might be right for
HypercholesterolemiaCoronary Heart DiseaseAtherosclerosis
AstraZeneca
Post-approval studies (Phase 4)UnknownNCT00885872
What this trial is testing

Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)

Who this might be right for
HyperlipidemiaAtherosclerosis
Chinese PLA General Hospital 60
Early research (Phase 1)Study completedNCT00826358
What this trial is testing

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Who this might be right for
Healthy
AstraZeneca 90
Not applicableLooking for participantsNCT06686615
What this trial is testing

Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2,000
Post-approval studies (Phase 4)Study completedNCT01178853
What this trial is testing

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

Who this might be right for
Healthy
Kowa Research Institute, Inc. 48
Post-approval studies (Phase 4)Study completedNCT03233243
What this trial is testing

Rosuvastatin Effect on Atherosclerotic Plaque Metabolism

Who this might be right for
Cardiovascular DiseasesAtherosclerosisMolecular Imaging
University of Coimbra 40
Large-scale testing (Phase 3)Study completedNCT03009487
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Who this might be right for
HypertensionHyperlipidemias
Daewoong Pharmaceutical Co. LTD. 265
Early research (Phase 1)Study completedNCT03806101
What this trial is testing

Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Who this might be right for
Healthy
Pfizer 12
Not applicableStudy completedNCT05741372
What this trial is testing

Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT02859129
What this trial is testing

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)

Who this might be right for
Hypertriglyceridemia
AstraZeneca 114
Large-scale testing (Phase 3)Study completedNCT00239330
What this trial is testing

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Who this might be right for
Hypercholesteremia
AstraZeneca 824
Large-scale testing (Phase 3)Study completedNCT02985099
What this trial is testing

1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

Who this might be right for
Chronic PeriodontitisType2 Diabetes
Government Dental College and Research Institute, Bangalore 80
Early research (Phase 1)Study completedNCT03307252
What this trial is testing

This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men

Who this might be right for
Healthy
Boehringer Ingelheim 45
Post-approval studies (Phase 4)UnknownNCT02532309
What this trial is testing

Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques

Who this might be right for
Carotid Atherosclerosis
Wei Liu 308
Large-scale testing (Phase 3)Study completedNCT00525824
What this trial is testing

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

Who this might be right for
HypercholesterolemiaCoronary Heart DiseaseAtherosclerosis
AstraZeneca 1,743
Early research (Phase 1)Study completedNCT01415466
What this trial is testing

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 36
Early research (Phase 1)Study completedNCT02704702
What this trial is testing

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 36
Large-scale testing (Phase 3)Study completedNCT00862251
What this trial is testing

Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)

Who this might be right for
Cardiovascular DisorderDiabetes Mellitus
Organon and Co 808
Large-scale testing (Phase 3)Ended earlyNCT01364220
What this trial is testing

The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke

Who this might be right for
Stroke
Severance Hospital 318
Early research (Phase 1)Study completedNCT06092931
What this trial is testing

A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Who this might be right for
Healthy Participants
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation